Aurora Spine Corporation Attends North American Spine Society (NASS) Annual Meeting, Canadian Business Journal

garretschoenbergOctober 11, 2022

CARLSBAD, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASPF) announced today, as a result of spinal surgery, announced that it will attend the 2022 North American Spine Society (“NASS”) Annual Meeting (Booth #4604), October 12-15 at the West Wing of McCormick Place in Chicago, Illinois. The North American Spine Society is a global, multidisciplinary medical association that uses teaching, research, and advocacy to advance the highest quality, ethical, and worthy evidence-based spine care.

At this year’s NASS event, Aurora Spine will showcase a product line that includes the newly FDA-cleared SiLO TFX SI Fusion System for use in patients requiring sacroiliac joint fusion surgery. Scheduled for launch in early 2023, the new system is a titanium implant specifically designed to fixate the sacrum and ilium, providing osseous fusion stability in the SI joint.

The company will also showcase its DEXA technology.^TMs Products also FDA cleared: DEXA-C, a line of cervical cages for anterior cervical discectomy (ACDF) procedures with fusion, and DEXA SOLO-L, anterior and lateral lumbar interbody fusion ( Standalone device for ALIF & LLIF) procedures. We use Aurora’s patented DEXA technology to create implants that match the patient’s bone density and DEXA T-score. The company will also showcase his ZIP product line, which offers screwless surgery and allows for his MIS interspinous fixation without the use of a screw set.

“We are very much looking forward to attending NASS, one of the industry’s top shows of the year. “We are gearing up for a meeting with physicians seeking new technologies to help improve patient outcomes. NASS will be a great place to showcase our DEXA franchise and key products such as ZIP and SiLO.” said Trent Northcutt, President and CEO of Aurora Spine. “We continue to build momentum in our sales pipeline as we continue to educate and train more physicians on the Aurora product. My team and I would like to host a great event with many new products and technologies that we have been working hard to bring to market and greet attendees. I look forward to the next years.”

About Aurora Spine

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.

Neither TSX Venture Exchange nor its regulated service providers (as those terms are defined in the TSX Venture Exchange Policy) are responsible for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking information that involves known and unknown risks and uncertainties. Most of which are beyond Aurora Spine’s control, including but not limited to those described in “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information”. Aurora Spine’s final prospectus (collectively, “Forward-Looking Information”). Forward-looking information in this news release includes information regarding the proposed use and success of the company’s products in surgical procedures. Aurora Spine advises investors in Aurora Spine securities about important factors that could cause Aurora Spine’s actual results to differ materially from those projected by the forward-looking statements contained in this news release. I warn you. Statements that express or involve expectations, beliefs, plans, objectives, assumptions, or discussions of future events or performance are not historical facts, may be forward-looking, and may not give rise to actual results or results. differ unilaterally from those expressed in such forward-looking statements that may involve certain estimates, assumptions and uncertainties. There is no guarantee that the expectations set forth herein will prove correct. These statements are current as of the date of this press release and Aurora Spine undertakes no obligation to update or revise them to reflect new events or circumstances.

contact:

Aurora Spine Corporation

Trent Northcutt

President and Chief Executive Officer

(760) 424-2004

Chad Close

CFO

(760) 424-2004

www.aurora-spine.com

Adam Lowensteiner

Lytham Partners LLC

Phoenix | Phoenix | New York